Full-Time

Director of Clinical Biomarkers

Posted on 11/7/2025

Recursion Pharmaceuticals

Recursion Pharmaceuticals

501-1,000 employees

Clinical-stage biotechnology company for drug discovery

Compensation Overview

$217.2k - $295.9k/yr

+ Annual bonus + Equity compensation

Salt Lake City, UT, USA + 3 more

More locations: London, UK | Oxford, UK | New York, NY, USA

Hybrid

Must spend 50% of time in the office.

Category
Biology & Biotech (2)
,
Requirements
  • PhD, MD or equivalent in a relevant scientific discipline with 8+ years of biopharmaceutical industry experience with a solid understanding of drug discovery and early development
  • Extensive experience in clinical biomarkers/diagnostics and/or translational research; Strong understanding of clinical studies and working within cross-functional study/program teams contributing to biomarker relevant documents, plans, operations and workstreams
  • Knowledge of regulatory requirements, best practices in applying translational science and biomarker assay development and validation to support global clinical trials
  • Strong understanding of various technology platforms and datasets, including omics, for discovery, validation and implementation of biomarkers; Familiarity with effectively engaging vendors and CROs providing services for biomarker assays
  • Expertise in one or more of the following therapeutic areas: oncology, rare disease, immunology/inflammation
  • Ability to think critically, strategically, practically to enable decision making and influence R&D teams and stakeholders; Track record in problem solving, data analysis/interpretation and team science innovation
Responsibilities
  • Lead the overall biomarker strategy and execution for assigned program(s) in the Recursion portfolio by serving as the clinical biomarker lead on program/study teams
  • Develop plans collaboratively to deliver fit-for-purpose pharmacodynamic, predictive, prognostic and/or other biomarker assays to support decision making in early development. Work with discovery teams to support preclinical to clinical transitions of programs and align overall translational and biomarker strategies
  • Partner with various research and clinical teams, including Clinical Operations, Stats, Data Management, Project Leadership, etc., to contribute to biomarker-related aspects of trial design and conduct, study documents (e.g. protocols, study reference manuals, study reports, INDs etc.), trial readouts/endpoints and regulatory interactions
  • Actively manage CROs, vendors, suppliers and other groups for assay development and qualification/validation. Oversee the operational aspects of biomarker implementation, including sample logistics, data management, and coordination with internal teams and CROs
  • Stay current with emerging science and innovate with novel technologies and approaches to generate/analyze/apply data and derive insights on mechanisms, indications, combinations and patient selection/stratification
  • Present biomarker findings at key internal and external meetings
Recursion Pharmaceuticals

Recursion Pharmaceuticals

View

Recursion is a clinical-stage biotechnology company utilizing a synchronized combination of hardware, software, and data to industrialize drug discovery and decode complex biology, reshaping the traditional drug discovery funnel through technological innovations. Their approach integrates biology, chemistry, automation, and data science to build a next-generation biopharmaceutical company.

Company Size

501-1,000

Company Stage

Post IPO Equity

Headquarters

Salt Lake City, Utah

Founded

2013

Your Connections

People at Recursion Pharmaceuticals who can refer or advise you

INACTIVE